Daniel Modulevsky

Scientist II at Spiderwort Inc.

No bio yet

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Spiderwort Inc.

Spiderwort is developing a novel biomaterial that will offer new avenues in regenerative medicine. We are using plant derived cellulose to create a variety of scaffold architectures. Currently, we are in the pre-clinical stage of this product and our promising results demonstrate that this new biomaterial is highly biocompatible and induceangiogenesis (blood vessel generation inside the scaffold).


Headquarters

Ottawa, Canada

Employees

11-50

Links